Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progesterone Effects on Smoking Urges in Women
NCT01811225Phase 2Completed
- Sponsor
- University of Minnesota
- Start
- Dec 2012
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of progesterone in nicotine dependence (2 arms), sponsored by University of Minnesota. Primary endpoint: Change in Smoking Urges at Day 8. Started Dec 2012; status: completed.
02
Drugs
progesterone
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT01811225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01811225.